Uniqure NV (NASDAQ:QURE)
| 18.06 Delayed Data As of 4:00pm ET |  +1.08 / +6.36%Today’s Change | 12.52 Today|||52-Week Range 36.55 | -12.92% Year-to-Date |
Latest QURE News | Press Releases
No recent news for Uniqure NV.
Today’s Trading
| Previous close | 16.98 |
| Today’s open | 17.59 |
| Day’s range | 17.58 - 18.06 |
| Volume | 22,653 |
| Average volume (3 months) | 715,244 |
| Market cap | $808.9M |
Data as of 4:00pm ET, 09/27/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -151.63% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +1,296.82% |
| P/E ratio | NM |
| Price/Sales | 1.85 |
| Price/Book | 1.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REPLReplimune Group Inc | +0.62 | +3.85% |
| ---- | ||
| RCKTRocket Pharmaceutica... | +0.94 | +7.49% |
| SGMOSangamo Therapeutics... | +0.23 | +4.81% |
Data as of 4:00pm ET, 09/27/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | -$1.20 |
| Annual revenue (last year) | $524.0M |
| Annual profit (last year) | $329.6M |
| Net profit margin | 62.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
